13F-HR filed by Euclidean Capital LLC
Euclidean Capital LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:05:23 UTC, with 10 holding rows worth $323,634,131.
- Accession
- 0001012975-26-001061
- Filer
- CIK 1825034
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 10 entries on the cover page, a total value of $323,634,131 stated on the cover page (in dollars after the unit check, H1), rows summing to $323,634,131 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Vanguard FTSE All-World ex-US ETF | 922042775 | SHS | 3,243,484 | $269,111,867 | dollars as filed | |
| ISHARES TR | 46429B598 | MSCI INDIA ETF | 369,600 | $17,252,928 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 989,410 | $13,327,353 | dollars as filed | |
| TEAMSHARES INC | 87821B109 | COM | 1,099,974 | $7,991,311 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 1,573,761 | $5,618,327 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 2,627,643 | $4,388,164 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 87,696 | $2,822,057 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,307,858 | $2,419,537 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 1,015,705 | $613,080 | dollars as filed | |
| MERLIN INC | 590106100 | COM | 47,610 | $89,507 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-26-001061 | this filing | 2026-11-16 |